KR101319135B1 - 재생 의약에서 성체 줄기 세포를 비롯한 세포 부분집합의 수집, 처리, 이식을 위한 통합된 기계 장치 - Google Patents
재생 의약에서 성체 줄기 세포를 비롯한 세포 부분집합의 수집, 처리, 이식을 위한 통합된 기계 장치 Download PDFInfo
- Publication number
- KR101319135B1 KR101319135B1 KR1020077022891A KR20077022891A KR101319135B1 KR 101319135 B1 KR101319135 B1 KR 101319135B1 KR 1020077022891 A KR1020077022891 A KR 1020077022891A KR 20077022891 A KR20077022891 A KR 20077022891A KR 101319135 B1 KR101319135 B1 KR 101319135B1
- Authority
- KR
- South Korea
- Prior art keywords
- chamber
- cells
- kit
- collection
- processing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 210000004027 cell Anatomy 0.000 title claims abstract description 100
- 238000012545 processing Methods 0.000 title claims abstract description 61
- 210000004504 adult stem cell Anatomy 0.000 title claims abstract description 10
- 230000001172 regenerating effect Effects 0.000 title abstract description 7
- 239000003814 drug Substances 0.000 title abstract description 5
- 229940079593 drug Drugs 0.000 title 1
- 238000011282 treatment Methods 0.000 claims abstract description 46
- 210000001185 bone marrow Anatomy 0.000 claims abstract description 28
- 210000000988 bone and bone Anatomy 0.000 claims abstract description 16
- 230000007246 mechanism Effects 0.000 claims abstract description 15
- 238000000605 extraction Methods 0.000 claims abstract description 12
- 238000000926 separation method Methods 0.000 claims description 35
- 238000000034 method Methods 0.000 claims description 29
- 239000007943 implant Substances 0.000 claims description 17
- 210000000130 stem cell Anatomy 0.000 claims description 17
- 230000008569 process Effects 0.000 claims description 13
- 239000012530 fluid Substances 0.000 claims description 10
- 238000002513 implantation Methods 0.000 claims description 8
- 210000000056 organ Anatomy 0.000 abstract description 4
- 238000011084 recovery Methods 0.000 abstract description 3
- 230000008439 repair process Effects 0.000 abstract description 2
- 210000003462 vein Anatomy 0.000 abstract 1
- 230000003287 optical effect Effects 0.000 description 14
- 239000000047 product Substances 0.000 description 12
- 210000001519 tissue Anatomy 0.000 description 10
- 239000013060 biological fluid Substances 0.000 description 8
- 210000000265 leukocyte Anatomy 0.000 description 8
- 210000003743 erythrocyte Anatomy 0.000 description 7
- 239000002609 medium Substances 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- 238000002054 transplantation Methods 0.000 description 7
- 238000010521 absorption reaction Methods 0.000 description 6
- 238000005119 centrifugation Methods 0.000 description 6
- 239000003634 thrombocyte concentrate Substances 0.000 description 6
- 239000007788 liquid Substances 0.000 description 5
- 239000011325 microbead Substances 0.000 description 5
- 239000002699 waste material Substances 0.000 description 5
- 210000004700 fetal blood Anatomy 0.000 description 4
- 210000005259 peripheral blood Anatomy 0.000 description 4
- 239000006228 supernatant Substances 0.000 description 4
- 210000000577 adipose tissue Anatomy 0.000 description 3
- 239000003146 anticoagulant agent Substances 0.000 description 3
- 229940127219 anticoagulant drug Drugs 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 238000011109 contamination Methods 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 210000003958 hematopoietic stem cell Anatomy 0.000 description 3
- 238000012544 monitoring process Methods 0.000 description 3
- 210000001616 monocyte Anatomy 0.000 description 3
- 239000011886 peripheral blood Substances 0.000 description 3
- 238000012546 transfer Methods 0.000 description 3
- 230000003321 amplification Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 238000004891 communication Methods 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 238000006073 displacement reaction Methods 0.000 description 2
- 210000001671 embryonic stem cell Anatomy 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 239000000644 isotonic solution Substances 0.000 description 2
- 210000002901 mesenchymal stem cell Anatomy 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 208000010125 myocardial infarction Diseases 0.000 description 2
- 238000003199 nucleic acid amplification method Methods 0.000 description 2
- 238000004062 sedimentation Methods 0.000 description 2
- 230000000699 topical effect Effects 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 230000029663 wound healing Effects 0.000 description 2
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- 229920001917 Ficoll Polymers 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 108090000190 Thrombin Proteins 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 206010000891 acute myocardial infarction Diseases 0.000 description 1
- 238000002583 angiography Methods 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 210000002459 blastocyst Anatomy 0.000 description 1
- 239000010836 blood and blood product Substances 0.000 description 1
- 229940125691 blood product Drugs 0.000 description 1
- 238000009583 bone marrow aspiration Methods 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 230000003822 cell turnover Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 230000003021 clonogenic effect Effects 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 210000003714 granulocyte Anatomy 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 230000011132 hemopoiesis Effects 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 230000008105 immune reaction Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 206010024378 leukocytosis Diseases 0.000 description 1
- 238000002690 local anesthesia Methods 0.000 description 1
- 210000001161 mammalian embryo Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000000399 orthopedic effect Effects 0.000 description 1
- 210000003049 pelvic bone Anatomy 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002062 proliferating effect Effects 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 230000011514 reflex Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 229960004072 thrombin Drugs 0.000 description 1
- 230000000451 tissue damage Effects 0.000 description 1
- 231100000827 tissue damage Toxicity 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 238000003466 welding Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
- A61M1/3693—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits using separation based on different densities of components, e.g. centrifuging
- A61M1/3698—Expressing processed fluid out from the turning rotor using another fluid compressing the treatment chamber; Variable volume rotors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/02—Blood transfusion apparatus
- A61M1/0209—Multiple bag systems for separating or storing blood components
- A61M1/0218—Multiple bag systems for separating or storing blood components with filters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
- A61M1/3693—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits using separation based on different densities of components, e.g. centrifuging
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2202/00—Special media to be introduced, removed or treated
- A61M2202/04—Liquids
- A61M2202/0413—Blood
- A61M2202/0429—Red blood cells; Erythrocytes
- A61M2202/0437—Blood stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2202/00—Special media to be introduced, removed or treated
- A61M2202/04—Liquids
- A61M2202/0413—Blood
- A61M2202/0462—Placental blood, umbilical cord blood
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2202/00—Special media to be introduced, removed or treated
- A61M2202/08—Lipoids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2202/00—Special media to be introduced, removed or treated
- A61M2202/10—Bone-marrow
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Vascular Medicine (AREA)
- Biomedical Technology (AREA)
- Physical Education & Sports Medicine (AREA)
- Hematology (AREA)
- Anesthesiology (AREA)
- Cardiology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- External Artificial Organs (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Materials For Medical Uses (AREA)
- Investigating Or Analysing Materials By Optical Means (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
Abstract
Description
Claims (19)
- 성체 줄기 세포와 혈소판을 비롯한 세포 부분집합(cell subset)을 추출하고, 수집하고, 처리하고, 그리고 이식하기 위한 기계 장치(system)에 있어서,상기 기계 장치는 한 세트의 일회용 무균 유체-수송 요소(disposable sterile fluid-transport element)를 포함하고,이러한 세트의 일회용 무균 유체-수송 요소는 팩 내에 포함되고, 이들 포함된 요소는 기능적으로 밀폐된 기계 장치를 제공하기 위하여 미리 연결되거나, 무균 커넥터를 보유하거나, 또는 무균 방식으로 이들 사이에 상호연결이 형성되도록 개조되고,상기 세트는- 환자로부터 골수, 또는 세포 부분집합의 다른 공급원을 추출하기 위하여, 골 또는 정맥 천자용 바늘을 보유하는 추출 장치;- 추출 장치에 의해 환자로부터 추출된 세포를 수집하기 위하여 상기 추출 장치에 미리 연결되거나 연결가능한 수집 챔버; 수집된 세포 상에서 처리와 전달 작업을 수행하는 처리 장비와 공조하도록 개조된 처리 챔버; 그리고 환자에게 환원되는 처리된 세포를 보관하기 위한 재주입 챔버를 비롯한, 환자로부터 추출된 세포 부분집합의 수집, 처리와 재주입을 위한 적어도 하나의 챔버; 여기서, 이들 수집, 처리와 재주입 챔버는 분리가능하고 미리-연결되거나 상호연결가능하고, 또는 다중-목적 처리 챔버가 수집-처리 챔버, 처리-재주입 챔버 또는 수집-처리-재주입 챔버의 복합 기능을 제공하고; 그리고- 처리된 세포를 환자에게 환원하기 위하여 재주입 챔버에 미리 연결되거나 연결가능한 이식 장치를 포함하는 것을 특징으로 하는 기계 장치.
- 청구항 1에 있어서, 한 세트의 일회용 요소는 서포트 상에서 블리스터(blister) 팩 내에 포장되고, 상기 블리스터 팩은 전체 상호연결된 세트를 수용하기 위한 하나의 구획(compartment), 또는 세트의 다른 부분에 연결을 위한 무균 커넥터를 보유하는, 상기 세트의 일부분을 각각 수용하는 복수의 구획을 보유하는 것을 특징으로 하는 기계 장치.
- 청구항 1 또는 2에 있어서, 한 세트의 일회용 요소는 일회용 요소의 3가지 키트: 수집 키트, 처리 키트, 그리고 이식 키트를 포함하고,상기 수집 키트는 단독으로, 또는 적어도 하나의 주사기, 수집 챔버를 형성하는 전달 봉지, 그리고 선택적으로, 처리 키트에 연결을 위한 무균 커넥터와 공동으로, 골수 추출기 장치를 포함하고;상기 처리 키트는 처리 챔버, 그리고 처리 챔버 내외로, 그리고 일회용 용기 내외로 유체의 선택적인 전달을 가능하게 하는 적어도 하나의 스톱콕 밸브 또는 멀티포트(mtltiport) 밸브를 통하여 상기 처리 챔버에 연결된 적어도 하나의 일회용 용기를 포함하고, 상기 처리 챔버는 수집 키트에 연결되거나, 수집 키트에 연결을 위한 무균 커넥터를 보유하거나, 또는 무균 연결이 형성되도록 개조되고, 상기 처리 챔버는 또한, 이식 키트에 연결되거나, 이식 키트에 연결을 위한 무균 커넥터를 보유하거나, 또는 무균 연결이 형성되도록 개조되고; 그리고상기 이식 키트는 적어도 하나의 이식 장치; 또는 적어도 하나의 이식 장치 및 수집 봉지, 수집 바이알과 주사기 중에서 적어도 한 가지의 조합을 포함하는 것을 특징으로 하는 기계 장치.
- 청구항 1 또는 2에 있어서, 처리 챔버는 처리되는 세포 및 처리된 세포에 대한 입구/출구를 보유하는 속이 빈 원심분리 처리 챔버이고, 상기 처리 챔버는 이들 세포를 수용하기 위한 가변 크기의 분리 공간을 한정하는 이동성 멤버를 보유하고, 상기 이동성 멤버는 처리되는 선택된 양의 세포를 상기 입구를 통하여 분리 챔버 내로 흡입하고 분리 챔버로부터 처리된 세포를 상기 출구를 통하여 급송하도록 이동되는 것을 특징으로 하는 기계 장치.
- 청구항 4에 있어서, 원심분리 처리 챔버는 일반적으로, 실린더형이고 실린더 축 주변으로 회전가능하며, 이동성 멤버는 원심분리 처리 챔버 내에서 유체가 새지 않으면서 이동가능하게 적재된 피스톤인 것을 특징으로 하는 기계 장치.
- 청구항 1 또는 2에 있어서,- 환자로부터 골수, 또는 세포 부분집합의 다른 공급원을 추출하기 위한 장치, 상기 장치는 추출된 줄기 세포를 처리 챔버 내에 수집하기 위하여 무균 연결에 의해 상기 처리 챔버에 연결가능하고;- 처리 챔버 내외로, 그리고 일회용 용기 내외로 유체의 선택적인 전달을 가능하게 하는 적어도 하나의 스톱콕 밸브 또는 멀티포트 밸브를 통하여 상기 처리 챔버에 연결된 적어도 하나의 일회용 용기, 상기 처리 챔버는 무균 커넥터를 통하여 스톱콕 밸브 또는 멀티포트 밸브에 연결가능하고; 그리고- 처리된 세포의 환자로의 전달을 위한 재주입 챔버로서 처리 챔버가 기능할 수 있도록 무균 연결에 의해 상기 처리 챔버에 연결가능한 적어도 하나의 이식 장치를 포함하는 것을 특징으로 하는 기계 장치.
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IBPCT/IB2005/000747 | 2005-03-23 | ||
IB2005000747 | 2005-03-23 | ||
PCT/IB2006/050895 WO2006100651A1 (en) | 2005-03-23 | 2006-03-23 | Integrated system for collecting, processing and transplanting cell subsets, including adult stem cells, for regenerative medicine |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20080020596A KR20080020596A (ko) | 2008-03-05 |
KR101319135B1 true KR101319135B1 (ko) | 2013-10-17 |
Family
ID=36698754
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020077022891A Expired - Fee Related KR101319135B1 (ko) | 2005-03-23 | 2006-03-23 | 재생 의약에서 성체 줄기 세포를 비롯한 세포 부분집합의 수집, 처리, 이식을 위한 통합된 기계 장치 |
Country Status (14)
Country | Link |
---|---|
US (1) | US20080171951A1 (ko) |
EP (1) | EP1893253B1 (ko) |
JP (1) | JP4846782B2 (ko) |
KR (1) | KR101319135B1 (ko) |
CN (1) | CN101146559B (ko) |
AT (1) | ATE468140T1 (ko) |
BR (1) | BRPI0609573A2 (ko) |
DE (1) | DE602006014399D1 (ko) |
DK (1) | DK1893253T3 (ko) |
ES (1) | ES2345837T3 (ko) |
MX (1) | MX2007011218A (ko) |
PT (1) | PT1893253E (ko) |
RU (1) | RU2410125C2 (ko) |
WO (1) | WO2006100651A1 (ko) |
Families Citing this family (109)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8048678B2 (en) * | 2005-10-27 | 2011-11-01 | Ecw Therapeutics, Inc. | Cell separation method and apparatus |
US7758556B2 (en) | 2006-03-23 | 2010-07-20 | Perez-Cruet Miguelangelo J | Device for collecting bone material during a surgical procedure |
KR20080037883A (ko) * | 2006-10-27 | 2008-05-02 | 세원셀론텍(주) | 메디컬 키트 및 이의 사용방법 |
US8409125B2 (en) | 2006-11-08 | 2013-04-02 | Haemonetics Corporation | Adaptable perioperative cell-salvage system and methods and disposable units for same |
US20170136158A1 (en) | 2015-10-16 | 2017-05-18 | Angiodynamics, Inc. | Systems and Methods for Removing Undesirable Material Within a Circulatory System |
US10517617B2 (en) | 2007-12-20 | 2019-12-31 | Angiodynamics, Inc. | Systems and methods for removing undesirable material within a circulatory system utilizing a balloon catheter |
DE102008004977A1 (de) * | 2008-01-17 | 2009-07-23 | Miltenyi Biotec Gmbh | Vorrichtung zur Entnahme von biologischem Material |
JP5427365B2 (ja) * | 2008-03-31 | 2014-02-26 | 株式会社クラレ | 液体成分回収装置およびこれを用いた体液成分回収方法 |
AU2008355075A1 (en) * | 2008-04-23 | 2009-10-29 | Osiris Therapeutics, Inc. | Methods, systems, and apparati for cellular therapeutic agent preparation and delivery |
RU2571230C2 (ru) | 2008-04-30 | 2015-12-20 | Дженомикс Ко., Лтд. | Способ сбора функциональных клеток in vivo с высокой эффективностью |
JP2010127620A (ja) * | 2008-11-25 | 2010-06-10 | Olympus Corp | 生体組織処理装置 |
US8309343B2 (en) | 2008-12-01 | 2012-11-13 | Baxter International Inc. | Apparatus and method for processing biological material |
US8470308B2 (en) * | 2009-01-03 | 2013-06-25 | Ray C. Wasielewski | Enhanced medical implant comprising disrupted tooth pulp and tooth particles |
US10328103B2 (en) | 2009-01-03 | 2019-06-25 | Ray C. Wasielewski | Medical treatment composition comprising mammalian dental pulp stem cells |
US20100172951A1 (en) * | 2009-01-03 | 2010-07-08 | Ray Wasielewski | Enhanced Medical Implant |
EP2435108B1 (en) | 2009-05-29 | 2016-12-07 | EndoCellutions, Inc. | Apparatus and methods for aspirating and separating components of different densities from a physiological fluid containing cells |
AU2010312537A1 (en) | 2009-10-28 | 2012-05-17 | Genomix Co., Ltd. | Tissue-regeneration promoter using recruitment of bone marrow mesenchymal stem cells and/or pluripotent stem cells in blood |
JP2011097878A (ja) * | 2009-11-06 | 2011-05-19 | Olympus Corp | 細胞分離装置 |
US8512566B2 (en) * | 2009-12-11 | 2013-08-20 | General Electric Company | Disposable fluid path systems and methods for processing complex biological materials |
US9034280B2 (en) * | 2009-12-16 | 2015-05-19 | General Electric Corporation | High-throughput methods and systems for processing biological materials |
US11213365B1 (en) * | 2010-05-19 | 2022-01-04 | Michael Angelillo | Arthrocentesis kit device |
KR101522888B1 (ko) | 2010-08-03 | 2015-05-26 | 훗카이도 코리츠 다이가쿠 호진 삿포르 이카 다이가쿠 | 자기혈청 첨가 골수세포 배양 시스템, 자기혈청 첨가 골수세포 배양방법 및 자기혈청 첨가 배양 골수세포를 유효성분으로 하는 의약조성물의 제조방법 |
US9055964B2 (en) | 2011-03-15 | 2015-06-16 | Angio Dynamics, Inc. | Device and method for removing material from a hollow anatomical structure |
US12245788B2 (en) | 2011-03-15 | 2025-03-11 | Angiodynamics, Inc. | Device and method for removing material from a hollow anatomical structure |
PL2703487T3 (pl) | 2011-04-26 | 2019-03-29 | StemRIM Inc. | Peptyd do indukowania regeneracji tkanki i jego stosowanie |
US11166451B2 (en) * | 2011-09-26 | 2021-11-09 | Rich Technologies Holding Company, Llc | Method for living tissue preservation |
US20130131546A1 (en) * | 2011-11-23 | 2013-05-23 | Harvest Technologies Corporation | System for collecting and processing bone marrow |
TR201802122T4 (tr) | 2012-10-25 | 2018-03-21 | Genomix Co Ltd | HMGB1 fragmanı kullanarak kardiyak infarksiyonun tedavisine yönelik yeni yöntem. |
TR201807769T4 (tr) | 2012-10-25 | 2018-06-21 | Genomix Co Ltd | HMGB1 fragmanı kullanılarak spinal kord yaralanmasının tedavi edilmesine yönelik yeni yöntem. |
US10603665B2 (en) | 2013-01-29 | 2020-03-31 | Endocellutions, Inc. | Cell concentration devices and methods that include an insert defining a lumen and a cannula assembly |
KR20150124982A (ko) * | 2013-03-04 | 2015-11-06 | 스위스 스템 셀 파운데이션 | 조직의 샘플로부터 세포를 추출하는 시스템 |
ITMO20130227A1 (it) * | 2013-08-02 | 2015-02-03 | Biomed Device Srl | Metodo e sistema per aliquotare grasso da liposuzione |
ITMO20130228A1 (it) * | 2013-08-02 | 2015-02-03 | Biomed Device Srl | Sistema e metodo per aliquotare grasso da liposuzione ai fini dell'uso e della crioconservazione |
JP6258021B2 (ja) * | 2013-11-29 | 2018-01-10 | 澁谷工業株式会社 | アイソレータ |
JP6311306B2 (ja) * | 2013-12-26 | 2018-04-18 | 株式会社Ihi | 細胞回収装置及び細胞培養システム |
WO2015149098A1 (de) * | 2014-03-31 | 2015-10-08 | Liporegena Gmbh | Vorrichtung zur entnahme und portionierung von fettgewebe |
DE102014006496A1 (de) * | 2014-05-06 | 2015-11-12 | Balluff STM GmbH | Verfahren und Sensor zur Fluid-Erkennung in transparenten Schläuchen |
RU2558981C1 (ru) * | 2014-07-25 | 2015-08-10 | Общество с ограниченной ответственностью "Научно-технический центр "Мепотекс" | Устройство для сбора и реинфузии крови |
GB2547350B (en) * | 2014-08-29 | 2022-05-04 | Synaptive Medical Inc | Molecular cell imaging using optical spectroscopy |
WO2016057664A1 (en) | 2014-10-07 | 2016-04-14 | Haemonetics Corporation | System and method for washing shed blood |
SG10202002324SA (en) | 2014-11-05 | 2020-05-28 | Juno Therapeutics Inc | Methods for transduction and cell processing |
JP6700282B2 (ja) * | 2014-12-19 | 2020-05-27 | ビオセフ エス・アー | 生物学的液体の連続処理 |
RU2680829C2 (ru) * | 2015-02-25 | 2019-02-28 | Автономное учреждение Ханты-Мансийского автономного округа-Югры "Югорский научно-исследовательский институт клеточных технологий с банком стволовых клеток" | Закрытая система для распределения гемопоэтических стволовых клеток в криопакет |
ITUB20154668A1 (it) | 2015-10-14 | 2017-04-14 | Mario Goisis | Dispositivo per la filtrazione del grasso estratto con procedure chirurgiche di liposuzione |
US11541161B2 (en) | 2016-06-24 | 2023-01-03 | Haemonetics Corporation | System and method for continuous flow red blood cell washing |
US20240018268A1 (en) | 2016-07-29 | 2024-01-18 | Juno Therapeutics, Inc. | Anti-idiotypic antibodies against anti-cd19 antibodies |
CN109890952A (zh) | 2016-09-12 | 2019-06-14 | 朱诺治疗学股份有限公司 | 灌注生物反应器袋装配 |
US11401494B2 (en) | 2016-09-14 | 2022-08-02 | Fenwal, Inc. | Cell processing system and method with fill options |
JP6989907B2 (ja) * | 2016-09-27 | 2022-02-15 | 吉和 米満 | 懸濁液を無菌的に処理するための器具 |
CN106383503A (zh) * | 2016-10-20 | 2017-02-08 | 广东省心血管病研究所 | 基于物联网的干细胞制剂生产流程传输控制系统 |
EP3858395A1 (en) | 2016-12-01 | 2021-08-04 | Fenwal, Inc. | Fill and finish systems and methods |
CA3045338A1 (en) | 2016-12-05 | 2018-06-14 | Juno Therapeutics, Inc. | Production of engineered cells for adoptive cell therapy |
KR102559262B1 (ko) | 2017-01-27 | 2023-07-25 | 가부시키가이샤 스템림 | 심근증, 진구성 심근경색 및 만성심부전의 치료약 |
MX2019010171A (es) | 2017-02-27 | 2019-10-15 | Juno Therapeutics Inc | Composiciones, articulos de fabricacion y metodos relacionados con la dosificacion en la terapia celular. |
KR20200064060A (ko) | 2017-07-29 | 2020-06-05 | 주노 쎄러퓨티크스 인코퍼레이티드 | 재조합 수용체를 발현하는 세포 증폭용 시약 |
JP7322003B2 (ja) | 2017-08-28 | 2023-08-07 | ユニバーシティ オブ ピッツバーグ -オブ ザ コモンウェルス システム オブ ハイヤー エデュケイション | 足底筋膜炎の治療及び脂肪移植に用いる方法及び装置 |
MA50079A (fr) | 2017-09-07 | 2020-07-15 | Juno Therapeutics Inc | Procédés d'identification de caractéristiques cellulaires relatives à des réponses associées à une thérapie cellulaire |
BR112020008565A2 (pt) | 2017-11-01 | 2020-10-20 | Juno Therapeutics Inc | processo para a produção de uma composição de célula t |
EP3704230B1 (en) | 2017-11-01 | 2024-10-23 | Juno Therapeutics, Inc. | Process for generating therapeutic compositions of engineered cells |
KR20200095487A (ko) | 2017-11-10 | 2020-08-10 | 주노 쎄러퓨티크스 인코퍼레이티드 | 폐쇄-시스템 극저온 용기 |
US11298403B2 (en) | 2017-12-01 | 2022-04-12 | StemRIM Inc. | Therapeutic agent for inflammatory bowel disease |
MA51114A (fr) | 2017-12-08 | 2020-10-14 | Juno Therapeutics Inc | Procédé de production d'une compositions de lymphocytes t modifiés |
SG11202005228YA (en) | 2017-12-08 | 2020-07-29 | Juno Therapeutics Inc | Serum-free media formulation for culturing cells and methods of use thereof |
JP2021505615A (ja) | 2017-12-08 | 2021-02-18 | ジュノー セラピューティクス インコーポレイテッド | 細胞療法および関連方法のための表現型マーカー |
US11191880B2 (en) | 2018-05-16 | 2021-12-07 | Fenwal, Inc. | Fill and finish systems and methods for small volume processing |
US20210163893A1 (en) | 2018-08-09 | 2021-06-03 | Juno Therapeutics, Inc. | Processes for generating engineered cells and compositions thereof |
WO2020033916A1 (en) | 2018-08-09 | 2020-02-13 | Juno Therapeutics, Inc. | Methods for assessing integrated nucleic acids |
WO2020056047A1 (en) | 2018-09-11 | 2020-03-19 | Juno Therapeutics, Inc. | Methods for mass spectrometry analysis of engineered cell compositions |
US12304933B2 (en) | 2018-10-05 | 2025-05-20 | StemRIM Inc. | Disease treatment drug based on mesenchymal-stem-cell mobilization |
US11607323B2 (en) | 2018-10-15 | 2023-03-21 | Howmedica Osteonics Corp. | Patellofemoral trial extractor |
CN109401962A (zh) * | 2018-10-17 | 2019-03-01 | 深圳市深研生物科技有限公司 | 一种制备细胞的方法 |
AU2019370705A1 (en) | 2018-10-31 | 2021-05-27 | Juno Therapeutics Gmbh | Methods for selection and stimulation of cells and apparatus for same |
MX2021005024A (es) | 2018-11-01 | 2021-07-21 | Juno Therapeutics Inc | Metodos de tratamiento que utilizan receptores de antigenos quimericos especificos para antigeno de maduracion de celulas b. |
SG11202104183RA (en) | 2018-11-06 | 2021-05-28 | Juno Therapeutics Inc | Process for producing genetically engineered t cells |
AU2019381827A1 (en) | 2018-11-16 | 2021-06-10 | Juno Therapeutics, Inc. | Methods of dosing engineered T cells for the treatment of B cell malignancies |
PT3886894T (pt) | 2018-11-30 | 2024-05-02 | Juno Therapeutics Inc | Métodos para dosagem e tratamento de malignidades de células b em terapia celular adotiva |
SG11202105502RA (en) | 2018-11-30 | 2021-06-29 | Juno Therapeutics Inc | Methods for treatment using adoptive cell therapy |
EP3983006A1 (en) | 2019-06-12 | 2022-04-20 | Juno Therapeutics, Inc. | Combination therapy of a cell-mediated cytotoxic therapy and an inhibitor of a prosurvival bcl2 family protein |
US11478755B2 (en) | 2019-08-15 | 2022-10-25 | Fenwal, Inc. | Small volume processing systems and methods |
EP4017527A1 (en) | 2019-08-22 | 2022-06-29 | Juno Therapeutics, Inc. | Combination therapy of a t cell therapy and an enhancer of zeste homolog 2 (ezh2) inhibitor and related methods |
JP2022546396A (ja) | 2019-08-30 | 2022-11-04 | ジュノー セラピューティクス インコーポレイテッド | 細胞を分類するための機械学習方法 |
US11559770B2 (en) | 2019-10-24 | 2023-01-24 | Fenwal, Inc. | Small volume processing systems and methods with capacitive sensing |
EP4051402A1 (en) | 2019-10-30 | 2022-09-07 | Juno Therapeutics GmbH | Cell selection and/or stimulation devices and methods of use |
WO2021092097A1 (en) | 2019-11-05 | 2021-05-14 | Juno Therapeutics, Inc. | Methods of determining attributes of therapeutic t cell compositions |
EP4069742A1 (en) | 2019-12-06 | 2022-10-12 | Juno Therapeutics, Inc. | Anti-idiotypic antibodies to gprc5d-targeted binding domains and related compositions and methods |
CA3163897A1 (en) | 2019-12-06 | 2021-06-10 | Juno Therapeutics, Inc. | Anti-idiotypic antibodies to bcma-targeted binding domains and related compositions and methods |
KR20220132527A (ko) | 2019-12-06 | 2022-09-30 | 주노 쎄러퓨티크스 인코퍼레이티드 | B 세포 악성 종양을 치료하기 위한 세포 요법과 연관된 독성 및 반응과 관련된 방법 |
WO2021151008A1 (en) | 2020-01-24 | 2021-07-29 | Juno Therapuetics, Inc. | Methods for dosing and treatment of follicular lymphoma and marginal zone lymphoma in adoptive cell therapy |
US20230090117A1 (en) | 2020-01-28 | 2023-03-23 | Juno Therapeutics, Inc. | Methods for t cell transduction |
WO2021163391A1 (en) | 2020-02-12 | 2021-08-19 | Juno Therapeutics, Inc. | Cd19-directed chimeric antigen receptor t cell compositions and methods and uses thereof |
JP2023519099A (ja) | 2020-02-12 | 2023-05-10 | ジュノー セラピューティクス インコーポレイテッド | Bcma指向性キメラ抗原受容体t細胞組成物ならびにその方法および使用 |
JP2023522857A (ja) | 2020-04-10 | 2023-06-01 | ジュノー セラピューティクス インコーポレイテッド | B細胞成熟抗原を標的とするキメラ抗原受容体によって操作された細胞療法に関する方法および使用 |
EP4150057A2 (en) | 2020-05-13 | 2023-03-22 | Juno Therapeutics, Inc. | Process for producing donor-batched cells expressing a recombinant receptor |
KR20230024283A (ko) | 2020-05-13 | 2023-02-20 | 주노 쎄러퓨티크스 인코퍼레이티드 | 임상 반응과 관련된 특징을 식별하는 방법 및 이의 용도 |
US20230324408A1 (en) | 2020-08-05 | 2023-10-12 | Juno Therapeutics, Inc. | Anti-idiotypic antibodies to ror1-targeted binding domains and related compositions and methods |
TWI832022B (zh) | 2020-11-20 | 2024-02-11 | 財團法人工業技術研究院 | 樣品分類裝置、樣品分類系統與樣品分類方法 |
WO2022133030A1 (en) | 2020-12-16 | 2022-06-23 | Juno Therapeutics, Inc. | Combination therapy of a cell therapy and a bcl2 inhibitor |
CN117321200A (zh) | 2021-03-22 | 2023-12-29 | 朱诺治疗学股份有限公司 | 评估病毒载体颗粒效力的方法 |
EP4314814A1 (en) | 2021-03-22 | 2024-02-07 | Juno Therapeutics, Inc. | Methods of determining potency of a therapeutic cell composition |
WO2022212400A1 (en) | 2021-03-29 | 2022-10-06 | Juno Therapeutics, Inc. | Methods for dosing and treatment with a combination of a checkpoint inhibitor therapy and a car t cell therapy |
EP4532695A1 (en) | 2022-05-25 | 2025-04-09 | Celgene Corporation | Methods of manufacturing t cell therapies |
WO2023230548A1 (en) | 2022-05-25 | 2023-11-30 | Celgene Corporation | Method for predicting response to a t cell therapy |
CN119546638A (zh) | 2022-06-22 | 2025-02-28 | 朱诺治疗学股份有限公司 | 用于cd19靶向的car t细胞的二线疗法的治疗方法 |
WO2024124132A1 (en) | 2022-12-09 | 2024-06-13 | Juno Therapeutics, Inc. | Machine learning methods for predicting cell phenotype using holographic imaging |
US20240285762A1 (en) | 2023-02-28 | 2024-08-29 | Juno Therapeutics, Inc. | Cell therapy for treating systemic autoimmune diseases |
WO2024220588A1 (en) | 2023-04-18 | 2024-10-24 | Juno Therapeutics, Inc. | Cytotoxicity assay for assessing potency of therapeutic cell compositions |
WO2024226858A1 (en) | 2023-04-26 | 2024-10-31 | Juno Therapeutics, Inc. | Methods for viral vector manufacturing |
WO2024243365A2 (en) | 2023-05-23 | 2024-11-28 | Juno Therapeutics, Inc. | Activation markers of t cells and method for assessing t cell activation |
WO2025089333A1 (ja) * | 2023-10-26 | 2025-05-01 | 公益財団法人京都大学iPS細胞研究財団 | 細胞製造装置の包装体、細胞製造方法およびそのための管理システム |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0912250A1 (en) * | 1996-04-24 | 1999-05-06 | Claude Fell | Cell separation system for biological fluids like blood |
US6264619B1 (en) | 1999-09-01 | 2001-07-24 | Becton, Dickinson And Company | Kit for drawing a blood sample |
JP2002533171A (ja) | 1998-12-24 | 2002-10-08 | ビオセフ エス・アー | 造血幹細胞の濃縮に特化した血液分離装置 |
WO2003009889A1 (de) | 2001-07-26 | 2003-02-06 | Cellgenix Technologie Transfer Gmbh | Verfahren zur anreicherung von zellen |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3650093A (en) * | 1970-01-08 | 1972-03-21 | Pall Corp | Sterile disposable medicament administration system |
JPS58131541A (ja) * | 1982-01-30 | 1983-08-05 | Shimadzu Corp | 白血球・ヘモグロビン量同時測定装置 |
JPH01280467A (ja) * | 1988-05-06 | 1989-11-10 | Asahi Medical Co Ltd | 血漿採取ユニット |
US5393101A (en) * | 1992-10-02 | 1995-02-28 | Pall Corporation | Connector assembly |
US5810398A (en) * | 1992-10-02 | 1998-09-22 | Pall Corporation | Fluid delivery systems and methods and assemblies for making connections |
EP0653062B1 (en) * | 1993-05-28 | 2003-05-02 | Baxter International Inc. | Continuous centrifugation process for the separation of biologic components from heterogeneous cell populations |
US6515016B2 (en) * | 1996-12-02 | 2003-02-04 | Angiotech Pharmaceuticals, Inc. | Composition and methods of paclitaxel for treating psoriasis |
EP1716885A3 (en) * | 1997-05-09 | 2006-11-15 | Pall Corporation | Connector assemblies, fluid systems, and methods for making a connection |
JP4061715B2 (ja) * | 1998-06-25 | 2008-03-19 | ニプロ株式会社 | 白血球の分離、濃縮方法 |
JP5068901B2 (ja) * | 1999-01-19 | 2012-11-07 | ユニバーシティ オブ ノース カロライナ アット チャペル ヒル | ヒト肝前駆細胞 |
US6306346B1 (en) * | 1999-02-10 | 2001-10-23 | Terumo Cardiovascular Systems Corporation | Self-contained pack assembly for an extracorporeal blood circuit |
US6994213B2 (en) * | 2001-09-18 | 2006-02-07 | Becton, Dickinson And Company | Packaging for push button blood collection set |
FR2851233B1 (fr) * | 2003-02-19 | 2006-05-05 | Maco Pharma Sa | Systeme a poches emballe pourvu de moyens d'identification |
-
2006
- 2006-03-23 DE DE602006014399T patent/DE602006014399D1/de active Active
- 2006-03-23 WO PCT/IB2006/050895 patent/WO2006100651A1/en active Application Filing
- 2006-03-23 BR BRPI0609573-9A patent/BRPI0609573A2/pt not_active Application Discontinuation
- 2006-03-23 CN CN2006800092581A patent/CN101146559B/zh not_active Expired - Fee Related
- 2006-03-23 RU RU2007136728/14A patent/RU2410125C2/ru active
- 2006-03-23 US US11/908,434 patent/US20080171951A1/en not_active Abandoned
- 2006-03-23 EP EP06727718A patent/EP1893253B1/en active Active
- 2006-03-23 MX MX2007011218A patent/MX2007011218A/es active IP Right Grant
- 2006-03-23 KR KR1020077022891A patent/KR101319135B1/ko not_active Expired - Fee Related
- 2006-03-23 DK DK06727718.6T patent/DK1893253T3/da active
- 2006-03-23 JP JP2008502550A patent/JP4846782B2/ja not_active Expired - Fee Related
- 2006-03-23 ES ES06727718T patent/ES2345837T3/es active Active
- 2006-03-23 PT PT06727718T patent/PT1893253E/pt unknown
- 2006-03-23 AT AT06727718T patent/ATE468140T1/de active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0912250A1 (en) * | 1996-04-24 | 1999-05-06 | Claude Fell | Cell separation system for biological fluids like blood |
JP2002533171A (ja) | 1998-12-24 | 2002-10-08 | ビオセフ エス・アー | 造血幹細胞の濃縮に特化した血液分離装置 |
US6264619B1 (en) | 1999-09-01 | 2001-07-24 | Becton, Dickinson And Company | Kit for drawing a blood sample |
WO2003009889A1 (de) | 2001-07-26 | 2003-02-06 | Cellgenix Technologie Transfer Gmbh | Verfahren zur anreicherung von zellen |
Also Published As
Publication number | Publication date |
---|---|
US20080171951A1 (en) | 2008-07-17 |
DE602006014399D1 (de) | 2010-07-01 |
JP4846782B2 (ja) | 2011-12-28 |
RU2410125C2 (ru) | 2011-01-27 |
BRPI0609573A2 (pt) | 2010-04-20 |
CN101146559A (zh) | 2008-03-19 |
PT1893253E (pt) | 2010-08-24 |
KR20080020596A (ko) | 2008-03-05 |
MX2007011218A (es) | 2007-10-17 |
DK1893253T3 (da) | 2010-08-16 |
JP2008538514A (ja) | 2008-10-30 |
CN101146559B (zh) | 2012-09-05 |
EP1893253B1 (en) | 2010-05-19 |
ATE468140T1 (de) | 2010-06-15 |
ES2345837T3 (es) | 2010-10-04 |
WO2006100651A1 (en) | 2006-09-28 |
HK1119094A1 (en) | 2009-02-27 |
EP1893253A1 (en) | 2008-03-05 |
RU2007136728A (ru) | 2009-04-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101319135B1 (ko) | 재생 의약에서 성체 줄기 세포를 비롯한 세포 부분집합의 수집, 처리, 이식을 위한 통합된 기계 장치 | |
US20210187181A1 (en) | Processing blood | |
JP2008538514A5 (ko) | ||
CN102458302A (zh) | 用于优化组织和细胞富集的移植物的系统、方法和组合物 | |
WO2015148390A1 (en) | Automated cell washing system and related method | |
HK1119094B (en) | Integrated system for collecting, processing and transplanting cell subsets, including adult stem cells, for regenerative medicine | |
HK1164187A (en) | Processing blood | |
HK1164187B (en) | Processing blood | |
HK1163569B (en) | Processing blood |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PA0105 | International application |
Patent event date: 20071008 Patent event code: PA01051R01D Comment text: International Patent Application |
|
PG1501 | Laying open of application | ||
A201 | Request for examination | ||
PA0201 | Request for examination |
Patent event code: PA02012R01D Patent event date: 20110322 Comment text: Request for Examination of Application |
|
E902 | Notification of reason for refusal | ||
PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20120923 Patent event code: PE09021S01D |
|
E902 | Notification of reason for refusal | ||
PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20130328 Patent event code: PE09021S01D |
|
E701 | Decision to grant or registration of patent right | ||
PE0701 | Decision of registration |
Patent event code: PE07011S01D Comment text: Decision to Grant Registration Patent event date: 20130729 |
|
GRNT | Written decision to grant | ||
PR0701 | Registration of establishment |
Comment text: Registration of Establishment Patent event date: 20131010 Patent event code: PR07011E01D |
|
PR1002 | Payment of registration fee |
Payment date: 20131010 End annual number: 3 Start annual number: 1 |
|
PG1601 | Publication of registration | ||
FPAY | Annual fee payment |
Payment date: 20160929 Year of fee payment: 4 |
|
PR1001 | Payment of annual fee |
Payment date: 20160929 Start annual number: 4 End annual number: 4 |
|
FPAY | Annual fee payment |
Payment date: 20181001 Year of fee payment: 6 |
|
PR1001 | Payment of annual fee |
Payment date: 20181001 Start annual number: 6 End annual number: 6 |
|
FPAY | Annual fee payment |
Payment date: 20191001 Year of fee payment: 7 |
|
PR1001 | Payment of annual fee |
Payment date: 20191001 Start annual number: 7 End annual number: 7 |
|
PR1001 | Payment of annual fee |
Payment date: 20210915 Start annual number: 9 End annual number: 9 |
|
PR1001 | Payment of annual fee |
Payment date: 20220830 Start annual number: 10 End annual number: 10 |
|
PC1903 | Unpaid annual fee |
Termination category: Default of registration fee Termination date: 20240721 |